SEMABIZ, Inc. | ChosaReport.com

日本と海外の市場調査レポート＆サービスを取り扱っております。

米国の腰再建市場：規模、動向、予測（2021-2025年版）

米国の腰再建市場：規模、動向、予測（2021-2025年版）The US Hip Reconstruction Market: Size, Trends and Forecasts (2021-2025 Edition)

このレポートへお問合せ

  
種別英文調査報告書
出版Daedal Research
出版年月2021年4月
ページ数83
図表数
価格（USD）
シングルユーザライセンス850
エンタープライズライセンス1400
 

レポート目次

  Report DetailsScope of the ReportThe report titled “The US Hip Reconstruction Market: Size, Trends and Forecasts (2021-2025 Edition)”, provides an in depth analysis of the US hip reconstruction market by value, by procedure volume, by type, etc. The report also provides a detailed analysis of the US primary total hip reconstruction market by value, and by type.The report also assesses the key opportunities in the market and outlines the factors that are and will be driving the growth of the industry. Growth of the US hip reconstruction market has also been forecasted for the period 2021-2025, taking into consideration the previous growth patterns, the growth drivers and the current and future trends.The hip reconstruction market is dominated by few players, but there are other new players, private label players as well. However, the competition in the US hip reconstruction market is dominated by Zimmer Biomet Holdings, Inc., Johnson & Johnson, Stryker Corporation and Smith & Nephew Plc, who are also profiled with their financial information and respective business strategies.Company CoverageZimmer Biomet Holdings Inc.Johnson & JohnsonStryker CorporationSmith & Nephew PlcExecutive SummaryThe hip reconstruction market can be segmented on the basis of type. There are four major types of hip reconstruction procedures: Primary Total Hip Reconstruction, Partial Hip Reconstruction, Hip Resurfacing and Revision Hip Reconstruction. Primary Total Hip Reconstruction is further segmented into three types: Cemented Hip Reconstruction, Cementless Hip Reconstruction and Hybrid Hip Reconstruction.The US hip reconstruction market has increased at a significant CAGR over the years and projections are made that the market would rise in the next four years i.e. 2021-2025 tremendously. The hip reconstruction market is expected to increase due to aging population, growing prevalence of arthritis, increasing obesity, growth in chronic diseases, escalating healthcare expenditure, etc. Yet the market faces some challenges such as high cost involved, regulatory risk, etc. Table of Contents1. Executive Summary2. Introduction2.1 Orthopedic Surgery: An Overview2.1.1 Types of Orthopedic Surgery2.2 Hip Reconstruction: An Overview2.2.1 Symptoms for Hip Reconstruction2.2.2 Indications for Hip Reconstruction2.2.3 Risks Associated with Hip Reconstruction Surgery2.3 Hip Reconstruction Segmentation: An Overview2.3.1 Hip Reconstruction Segmentation by Type2.3.2 Hip Reconstruction Segmentation by End-users3. Global Market Analysis3.1 Global Hip Reconstruction Market: An Analysis3.1.1 Global Hip Reconstruction Market by Value3.1.2 Global Hip Reconstruction Market by Procedure Volume3.1.3 Global Hip Reconstruction Market Value by Region (The US, Europe & Rest of the World)3.1.4 Global Hip Reconstruction Procedure Volume by Region (The US, Germany, France, UK, Italy & Spain)4. The US Market Analysis4.1 The US Hip Reconstruction Market: An Analysis4.1.1 The US Hip Reconstruction Market by Value4.1.2 The US Hip Reconstruction Market by Procedure Volume4.1.3 The US Hip Reconstruction Market Value by Type (Primary Total Hip Reconstruction, Partial Hip Reconstruction, Revision Hip Reconstruction & Hip Resurfacing)4.1.4 The US Hip Reconstruction Procedure Volume by Type (Primary Total Hip Reconstruction, Partial Hip Reconstruction, Revision Hip Reconstruction & Hip Resurfacing)4.2 The US Hip Reconstruction Market: Type Analysis4.2.1 The US Primary Total Hip Reconstruction Market by Value4.2.2 The US Primary Total Hip Reconstruction Market by Procedure Volume4.2.3 The US Primary Total Hip Reconstruction Market by Type (Cementless, Hybrid & Cemented)4.2.4 The US Primary Total Hip Reconstruction Procedure Volume by Type (Cementless, Hybrid & Cemented)4.2.5 The US Cemented Primary Total Hip Reconstruction Market by Value4.2.6 The US Cemented Primary Total Hip Reconstruction Market by Procedure Volume4.2.7 The US Cementless Primary Total Hip Reconstruction Market by Value4.2.8 The US Cementless Primary Total Hip Reconstruction Market by Procedure Volume4.2.9 The US Hybrid Primary Total Hip Reconstruction Market by Value4.2.10 The US Hybrid Primary Total Hip Reconstruction Market by Procedure Volume4.2.11 The US Partial Hip Reconstruction Market by Value4.2.12 The US Partial Hip Reconstruction Market by Procedure Volume4.2.13 The US Revision Hip Reconstruction Market by Value4.2.14 The US Revision Hip Reconstruction Market by Procedure Volume4.2.15 The US Hip Resurfacing Market by Value4.2.16 The US Hip Resurfacing Market by Procedure Volume5. Market Dynamics5.1 Growth Driver5.1.1 Aging Population5.1.2 Rise in Urban Population5.1.3 Growing Prevalence of Arthritis5.1.4 Increasing Obesity5.1.5 Growth in Chronic Diseases5.1.6 Escalating Healthcare Expenditure5.2 Challenges5.2.1 Shortage of Orthopedic Surgeons5.2.2 High Cost Involved5.2.3 In-surgery and Post-Surgery Complications5.2.4 Regulatory Risk5.3 Market Trends5.3.1 Increasing Acceptance of Minimally Invasive Hip Reconstructions5.3.2 Rising Preference for Reverse Hybrid Hip Reconstructions5.3.3 Growing Popularity of Hip Resurfacing6. Competitive Landscape6.1 The US Hip Reconstruction Market Players: A Financial Comparison6.2 The US Hip Reconstruction Players by Market Share7. Company Profiles7.1 Zimmer Biomet Holdings, Inc.7.1.1 Business Overview7.1.2 Financial Overview7.1.3 Business Strategy7.2 Johnson & Johnson7.2.1 Business Overview7.2.2 Financial Overview7.2.3 Business Strategy7.3 Stryker Corporation7.3.1 Business Overview7.3.2 Financial Overview7.3.3 Business Strategy7.4 Smith & Nephew Plc7.4.1 Business Overview7.4.2 Financial Overview7.4.3 Business StrategyList of FiguresFigure 1: Types of Orthopedic SurgeryFigure 2: Symptoms for Hip ReconstructionFigure 3: Indications for Hip ReconstructionFigure 4: Risks Associated with Hip Reconstruction SurgeryFigure 5: Hip Reconstruction Segmentation by TypeFigure 6: Hip Reconstruction Segmentation by End-usersFigure 7: Global Hip Reconstruction Market by Value; 2016-2020 (US$ Billion)Figure 8: Global Hip Reconstruction Market by Value; 2021-2025 (US$ Billion)Figure 9: Global Hip Reconstruction Market by Procedure Volume; 2016-2020 (Million)Figure 10: Global Hip Reconstruction Market by Procedure Volume; 2021-2025 (Million)Figure 11: Global Hip Reconstruction Market Value by Region; 2020 (Percentage, %)Figure 12: Global Hip Reconstruction Procedure Volume by Region; 2020 (Percentage, %)Figure 13: The US Hip Reconstruction Market by Value; 2016-2020 (US$ Billion)Figure 14: The US Hip Reconstruction Market by Value; 2021-2025 (US$ Billion)Figure 15: The US Hip Reconstruction Market by Procedure Volume; 2016-2020 (Thousand)Figure 16: The US Hip Reconstruction Market by Procedure Volume; 2021-2025 (Thousand)Figure 17: The US Hip Reconstruction Market Value by Type; 2020 (Percentage, %)Figure 18: The US Hip Reconstruction Procedure Volume by Type; 2020 (Percentage, %)Figure 19: The US Primary Total Hip Reconstruction Market by Value; 2016-2020 (US$ Billion)Figure 20: The US Primary Total Hip Reconstruction Market by Value; 2021-2025 (US$ Billion)Figure 21: The US Primary Total Hip Reconstruction Market by Procedure Volume;2016-2020 (Thousand)Figure 22: The US Primary Total Hip Reconstruction Market by Procedure Volume;2021-2025 (Thousand)Figure 23: The US Primary Total Hip Reconstruction Market by Type; 2020 (Percentage, %)Figure 24: The US Primary Total Hip Reconstruction Procedure Volume by Type; 2020 (Percentage, %)Figure 25: The US Cemented Primary Total Hip Reconstruction Market by Value; 2016-2020 (US$ Million)Figure 26: The US Cemented Primary Total Hip Reconstruction Market by Value; 2021-2025 (US$ Million)Figure 27: The US Cemented Primary Total Hip Reconstruction Market by Procedure Volume; 2016-2020 (Thousand)Figure 28: The US Cemented Primary Total Hip Reconstruction Market by Procedure Volume; 2021-2025 (Thousand)Figure 29: The US Cementless Primary Total Hip Reconstruction Market by Value; 2016-2020 (US$ Billion)Figure 30: The US Cementless Primary Total Hip Reconstruction Market by Value; 2021-2025 (US$ Billion)Figure 31: The US Cementless Primary Total Hip Reconstruction Market by Procedure Volume; 2016-2020 (Thousand)Figure 32: The US Cementless Primary Total Hip Reconstruction Market by Procedure Volume; 2021-2025 (Thousand)Figure 33: The US Hybrid Primary Total Hip Reconstruction Market by Value; 2016-2020 (US$ Million)Figure 34: The US Hybrid Primary Total Hip Reconstruction Market by Value; 2021-2025 (US$ Million)Figure 35: The US Hybrid Primary Total Hip Reconstruction Market by Procedure Volume;2016-2020 (Thousand)Figure 36: The US Hybrid Primary Total Hip Reconstruction Market by Procedure Volume;2021-2025 (Thousand)Figure 37: The US Partial Hip Reconstruction Market by Value; 2016-2020 (US$ Million)Figure 38: The US Partial Hip Reconstruction Market by Value; 2021-2025 (US$ Million)Figure 39: The US Partial Hip Reconstruction Market by Procedure Volume; 2016-2020 (Thousand)Figure 40: The US Partial Hip Reconstruction Market by Procedure Volume; 2021-2025 (Thousand)Figure 41: The US Revision Hip Reconstruction Market by Value; 2016-2020 (US$ Million)Figure 42: The US Revision Hip Reconstruction Market by Value; 2021-2025 (US$ Million)Figure 43: The US Revision Hip Reconstruction Market by Procedure Volume; 2016-2020 (Thousand)Figure 44: The US Revision Hip Reconstruction Market by Procedure Volume; 2021-2025 (Thousand)Figure 45: The US Hip Resurfacing Market by Value; 2016-2020 (US$ Million)Figure 46: The US Hip Resurfacing Market by Value; 2021-2025 (US$ Million)Figure 47: The US Hip Resurfacing Market by Procedure Volume; 2016-2020 (Thousand)Figure 48: The US Hip Resurfacing Market by Procedure Volume; 2021-2025 (Thousand)Figure 49: The US Aging Population; 2010-2050 (Percentage, %)Figure 50: The US Urban Population; 2015-2020 (Million)Figure 51: The US Arthritis Population; 2010-2040 (Million)Figure 52: The US Symptomatic Hip Osteoarthritis Patients; 2015-2020 (Thousand)Figure 53: The US Obesity Rates; 2015-2030 (Percentage, %)Figure 54: The US Chronic Diseases Growth Rate; 2016-2025 (Percentage, %)Figure 55: The US Healthcare Expenditure; 2012-2024 (US$ Trillion)Figure 56: The US Hip Reconstruction Players by Market Share; 2019-2020 (Percentage, %)Figure 57: Zimmer Biomet Holdings, Inc. Net Sales; 2016-2020 (US$ Billion)Figure 58: Zimmer Biomet Holdings, Inc. Net Sales by Product; 2020 (Percentage, %)Figure 59: Zimmer Biomet Holdings, Inc. Net Sales by Region; 2020 (Percentage, %)Figure 60: Johnson & Johnson Sales; 2016-2020 (US$ Billion)Figure 61: Johnson & Johnson Sales by Segments; 2020 (Percentage, %)Figure 62: Johnson & Johnson Sales by Region; 2020 (Percentage, %)Figure 63: Stryker Corporation Net Sales; 2016-2020 (US$ Billion)Figure 64: Stryker Corporation Net Sales by Segments; 2020 (Percentage, %)Figure 65: Stryker Corporation Net Sales by Region; 2020 (Percentage, %)Figure 66: Smith & Nephew Plc Revenue; 2016-2020 (US$ Billion)Figure 67: Smith & Nephew Plc Revenue by Products; 2020 (Percentage, %)Figure 68: Smith & Nephew Plc Revenue by Region; 2020 (Percentage, %)Table 1: The US Hip Reconstruction Market Players: A Financial Comparison; 2020お問合せフォーム

    お問合せフォーム

    • *のある項目は必須項目です。

    • レポートのタイトルは自動で入ります。

    • 無料サンプルはご購入を検討されている方向けのレポート形式等確認用資料です。
      重要記述や数値は記載されていません。予めご了承ください。

    お名前*

    会社名*

    部署名

    メールアドレス*

    電話番号

    当ウェブサイトを知った経緯を教えてください。

    お問合せ内容

    株式会社SEMABIZ・ChosaReport.com プライバシーポリシー

    Eメールでのお問合せもお受けしております。
    下記アドレスへ“(at)”を“@”に変えてお送りください。通常1営業日以内にご返信いたします。
    crinquiry(at)chosareport.com

    プライバシーポリシーはこちらをご覧ください。

    その他の最新記事8件